Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1215-1215
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 157
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2669-2683
Open Access | Times Cited: 77
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps
Eugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 7, pp. 1195-1205
Open Access | Times Cited: 9
Comparative real‐world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients
Eugenio De Corso, Davide Paolo Porru, Marco Corbò, et al.
Clinical Otolaryngology (2024) Vol. 49, Iss. 4, pp. 481-489
Closed Access | Times Cited: 8
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients
Alberto Macchi, Alessia Giorli, Elena Cantone, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 20
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
Eugenio De Corso, Stefano Settimi, Claudio Montuori, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 2 (Suppl. 1), pp. S3-S13
Open Access | Times Cited: 17
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
Giancarlo Ottaviano, Eugenio De Corso, Elena Cantone, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 234-234
Open Access | Times Cited: 14
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Adherence to Intranasal Steroids in Chronic Rhinosinusitis with Nasal Polyposis Prior to and during Biologic Therapy: A Neglected Matter
Francesca Norelli, Michele Schiappoli, Gianenrico Senna, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 5
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report
Pietro Orlando, Giuseppe Licci, Donald Kuitche, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 3, pp. 1317-1324
Closed Access | Times Cited: 11
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey
Francesca Anastasi, Frank Rikki Canevari, Stefania Gallo, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Comprehensive Olfactory Outcomes of Dupilumab in the Treatment of Chronic Rhinosinusitis With Polyposis
Babak Pourmomenarabi, Taciano Rocha, Michal Kahanovitch, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Correlation Between Smell Recovery and Nasal Polyp Score in Patients Treated with Dupilumab: A Real-Life Retrospective, Observational, Monocentric Study
Giovanna Stilo, Giuliano Messina, Carmelo Lo Faro, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 5, pp. 164-164
Open Access
Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 5, pp. 324-340
Open Access | Times Cited: 10
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
Long-Term Efficacy of Dupilumab for Eosinophilic Chronic Rhinosinusitis
Yasuhiro Tsunemi, Tsuguhisa Nakayama, Takashi Kashiwagi, et al.
American Journal of Rhinology and Allergy (2023) Vol. 38, Iss. 1, pp. 14-22
Closed Access | Times Cited: 10
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)
Eugenio De Corso, Carlotta Pipolo, Marco Caminati, et al.
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 3, pp. 143-154
Closed Access | Times Cited: 2
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
Eugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 5, pp. 2429-2440
Closed Access | Times Cited: 6
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment
Sara Torretta, Eugenio De Corso, Nicolò Nava, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1734-1734
Open Access | Times Cited: 9
Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice
Eugenio De Corso, Giancarlo Ottaviano, Carlotta Pipolo, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1531-1531
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top